Christopher Svendsen Associate Litigation Christopher represents technology and life sciences companies in a broad range of patent litigation matters.
Publications Federal Circuit Denies Request to Block Disclosure of Litigation Funding Information December 13, 2022
Publications The Long Arm of the Lanham Act? Supreme Court to Consider Foreign Reach of US Law November 15, 2022
Experience Fenwick Represents Royalty Pharma in Acquisition of Royalty Interest in siRNA Drug Olpasiran from Arrowhead Pharmaceuticals in Deal Totaling Up to $410M November 9, 2022
